Alerts will be sent to your verified email
Verify Email
FISCHER
|
Fischer Medical
|
Thirumalai Chemicals
|
NOCIL
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.29 % | 8.15 % | 8.47 % |
|
5yr average Equity Multiplier
|
0.49 | 2.31 | 1.22 |
|
5yr Average Asset Turnover Ratio
|
0.4 | 0.79 | 0.74 |
|
5yr Avg Net Profit Margin
|
-4.14 % | 5.0 % | 9.32 % |
|
Price to Book
|
6.39 | 1.49 | 1.21 |
|
P/E
|
115.43 | 0.0 | 33.98 |
|
5yr Avg Cash Conversion Cycle
|
140.14 Days | -32.58 Days | 115.35 Days |
|
Inventory Days
|
33.45 Days | 44.63 Days | 63.49 Days |
|
Days Receivable
|
163.11 Days | 34.03 Days | 85.23 Days |
|
Days Payable
|
23.17 Days | 116.12 Days | 51.92 Days |
|
5yr Average Interest Coverage Ratio
|
12.88 | 6.68 | 135.89 |
|
5yr Avg ROCE
|
3.71 % | 11.74 % | 10.21 % |
|
5yr Avg Operating Profit Margin
|
6.78 % | 11.19 % | 14.27 % |
|
5 yr average Debt to Equity
|
-0.66 | 0.65 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | n/a | 3.07 % |
|
5yr Average Return on Assets
|
-4.27 % | 5.06 % | 6.95 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
61.8 % | 36.13 % | 33.76 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 18.66 % |
|
Change in Promoter Holding (3 Yrs)
|
61.8 % | -5.85 % | -0.08 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 8.11 % | 2.27 % |
|
Fischer Medical
|
Thirumalai Chemicals
|
NOCIL
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|